<DOC>
	<DOCNO>NCT02524418</DOCNO>
	<brief_summary>This prospective evaluation clinical utility new cholangioscopy platform SpyGlass DS . The aim study prospectively document clinical utility technical aspect ERCP cholangioscopy and/or pancreatoscopy diagnosis management pancreatic-biliary disorder .</brief_summary>
	<brief_title>Clinical Utility ERCP Guided Cholangiopancreatoscopy With SpyGlass DS</brief_title>
	<detailed_description>Cholangioscopy allow direct visualization bile pancreatic duct . In 2006 , SpyGlass Direct Visualization System per-oral cholangiopancreatoscopy introduce since show provide incremental diagnostic therapeutic benefit . The main limitation original SpyGlass platform fiber optic visualization system , limited tip angulation , square cut Spy scope tip , complex multi-component setup . A new generation cholangioscopy platform , SpyGlass DS currently clinical use . The new system address many shortcoming old platform include digital optic , improve tip angulation , taper tip simplify set . It unclear time whether technical improvement translate well outcomes . Therefore , investigator want study clinical utility SpyGlass DS prospectively collect data clinical outcome patient undergo cholangioscopy Spyglass DS part routine medical care .</detailed_description>
	<mesh_term>Biliary Tract Diseases</mesh_term>
	<criteria>Participants schedule undergo cholangiopancreatoscopy routine clinical care failure provide inform consent contraindication endoscopy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Main Pancreatic Duct</keyword>
</DOC>